NICE Pricey, But Available The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian. Breast Cancer Molecular Tests Included in Recommendations by UK's NICE The group recommends Myriad Genetics' EndoPredict, NanoString's Prosigna, and Genomic Health's Oncotype DX tests for guiding chemotherapy decisions if certain conditions are met. UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments Premium Although a draft guidance last month recommended against use of molecular tests to guide chemotherapy, the group's finalized decision is subject to price negotiation and other adjustments. NICE Draft Guidance Reverses Endorsement of Oncotype Dx to Guide Chemotherapy An assessment concluded that Oncotype Dx has not demonstrated a significant enough impact on outcomes or cost effectiveness compared to current practice. UK's NHS Adopts NICE Advice to Provide Oncotype DX for Intermediate Risk Breast Cancer Patients The NICE recommendation specifies the use of Oncotype DX for intermediate risk patients for whom doctors are unclear whether to prescribe chemotherapy. Feb 25, 2013 Most Viewed Articles on GWDN Last Week: Feb 25, 2013 Feb 20, 2013 In Preliminary Recommendation, UK's NICE Backs Oncotype DX in Subset of Breast Cancer Patients Premium Jan 23, 2013 UK's NICE Seeks Comments on Updated Guidelines for Familial Breast Cancer Genetic Testing, Treatment Premium Nov 2, 2012 UK Study Suggests VEGF Splice Isoform Ratio Could Predict Colorectal Cancer Patients' Avastin Response Premium Sep 12, 2012 During Investor Day, Roche Highlights Personalized Medicine as Key Area for Future Growth Premium May 2, 2012 Merck Serono Survey Finds Limited Test Access, High Costs a Barrier to Personalized Rx Adoption in UK Premium Feb 22, 2012 Lab21 Offering Companion Testing to Personalize ALK Inhibitors for NSCLC Patients Premium Feb 8, 2012 Breast Cancer Test Makers Will Attempt to Sway UK's NICE in Wake of Initial Negative Opinion Premium Oct 19, 2011 UK's NICE Cites Lack of Response Markers for BMS' Yervoy as Factor in Negative Recommendation Premium Jun 8, 2011 Q&A: NICE's Nick Crabb on Assessing Drugs and Diagnostics for the UK Medical System Premium Feb 23, 2011 NICE Agrees With FDA in Pulling Avastin's Indication for Metastatic Breast Cancer Premium Feb 16, 2011 Cancer Research UK on Path to Building National Genetic Testing Service Premium Aug 25, 2010 Despite PGx Leads, Avastin Access Debate Not Focused on Personalized Medicine Strategies Premium Jun 2, 2010 UK's NICE Backs Iressa Coverage at Fixed Price; NHS Pays for Genetic Testing Premium Apr 28, 2010 Resuscitation Uncertain: Can Debiopharm Help Revive Pfizer's Failed Melanoma Drug? Premium Apr 21, 2010 With New Hires to Pharma Business Development Team, Qiagen Prioritizes Rx/Dx Partnership Strategy Premium Apr 7, 2010 AstraZeneca Paying for Genetic Testing Services for UK Lung Cancer Patients Receiving Iressa Premium Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.